FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kirk Wojno

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Co-author Network

Publications

TOP 3
Mark A Moyad; Kirk J Wojno
Molecular markers that can be utilized in diet and dietary supplement research.
Conrad David Valdez; Kirk J Wojno; David G Johnson; Tristan L Layfield; Hana M Odeh; Thomas R Berton; Craig S Cousineau; Joanne N Davis; Mark Day
Repression of androgen receptor transcription through the E2F1/DNMT1 axis.
Timothy L Hall; Christopher R Hempel; Kirk J Wojno; Zhen Xu; Charles A Cain; William W Roberts
Histotripsy of the prostate: dose effects in a chronic canine model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kirk Wojno (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Mark A Moyad; Kirk J Wojno
Molecular markers that can be utilized in diet and dietary supplement research.
The Urologic clinics of North America 2011;38(3):321-4.
2011: Conrad David Valdez; Kirk J Wojno; David G Johnson; Tristan L Layfield; Hana M Odeh; Thomas R Berton; Craig S Cousineau; Joanne N Davis; Mark Day
Repression of androgen receptor transcription through the E2F1/DNMT1 axis.
PloS one 2011;6(9):e25187.
2009: Timothy L Hall; Christopher R Hempel; Kirk J Wojno; Zhen Xu; Charles A Cain; William W Roberts
Histotripsy of the prostate: dose effects in a chronic canine model.
Urology 2009;74(4):932-7.
2009: Rou Wang; Arul M Chinnaiyan; Rodney L Dunn; Kirk J Wojno; John T Wei
Rational approach to implementation of prostate cancer antigen 3 into clinical care.
Cancer 2009;115(17):3879-86.
2008: Dweepanita Das; Kirk J Wojno; Michael J Imperiale
BK virus as a cofactor in the etiology of prostate cancer in its early stages.
Journal of virology 2008;82(6):2705-14.
2008: Lakshmi P Kunju; Kirk J Wojno; J. Stuart Wolf, Jr.; Liang Cheng; Rajal B Shah
Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features.
Human pathology 2008;39(1):96-101.
2008: Megan Albertelli; Orla A O'Mahony; Michele Brogley; Jeffrey Tosoian; Mara Steinkamp; Stephanie Daignault; Kirk J Wojno; Diane M Robins
Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice.
Human molecular genetics 2008;17(1):98-110.
2007: Robert D Loberg; Chi Ying; Matthew Craig; LaShon L Day; Erin Sargent; Chris K Neeley; Kirk J Wojno; Linda A Snyder; Li Yan; Kenneth J Pienta
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo.
Cancer research 2007;67(19):9417-24.
2007: Irwin H Lee; Rebecca Roberts; Rajal B Shah; Kirk J Wojno; John T Wei; Howard M Sandler
Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer.
International journal of radiation oncology, biology, physics 2007;68(4):1059-64.
2007: Christoph S Zorn; Kirk J Wojno; Michael T. McCabe; Rainer Kuefer; Juergen E Gschwend; Mark Day
5-aza-2'-deoxycytidine delays androgen-independent disease and improves survival in the transgenic adenocarcinoma of the mouse prostate mouse model of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2136-43.
2007: Benjamin Bruce; Gaurav Khanna; Ling Ren; Göran Landberg; Karin Jirström; Charles A Powell; Alain C Borczuk; Evan T Keller; Kirk J Wojno; Paul Meltzer; Kristin Baird; Andrea I McClatchey; Anthony Bretscher; Stephen M Hewitt; Chand Khanna
Expression of the cytoskeleton linker protein ezrin in human cancers.
Clinical & experimental metastasis 2007;24(2):69-78.
2006: Joanne N Davis; Kirk J Wojno; Stephanie Daignault; Matthias D Hofer; Rainer Kuefer; Mark A Rubin; Mark Day
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Cancer research 2006;66(24):11897-906.
2006: Michael E Ray; Kirk J Wojno; Neal S Goldstein; Karin B Olson; Rajal B Shah; Kathleen Cooney
Clonality of sarcomatous and carcinomatous elements in sarcomatoid carcinoma of the prostate.
Urology 2006;67(2):423.e5-423.e8.
2006: Susan L Slager; Katherine E Zarfas; W Mark Brown; Ethan M Lange; Shannon K McDonnell; Kirk J Wojno; Kathleen Cooney
Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project.
The Prostate 2006;66(2):173-9.
2006: Kirsten A White; Ethan M Lange; Anna M Ray; Kirk J Wojno; Kathleen Cooney
Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
Prostate cancer and prostatic diseases 2006;9(3):298-302.
2006: Michael T. McCabe; Jonathan A Low; Stephanie Daignault; Michael J Imperiale; Kirk J Wojno; Mark Day
Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer.
Cancer research 2006;66(1):385-92.
2005: Robert D Loberg; Kirk J Wojno; LaShon L Day; Kenneth J Pienta
Analysis of membrane-bound complement regulatory proteins in prostate cancer.
Urology 2005;66(6):1321-6.
2005: Gina B Claeys; Aruna V Sarma; Rodney L Dunn; Kimberly A Zuhlke; Jennifer L Beebe; James E Montie; Kirk J Wojno; David Schottenfeld; Kathleen Cooney
INSPstI polymorphism and prostate cancer in African-American men.
The Prostate 2005;65(1):83-7.
2004: Chakshu Gupta; Jian Z Ren; Kirk J Wojno
Individual submission and embedding of prostate biopsies decreases rates of equivocal pathology reports.
Urology 2004;63(1):83-6.
2003: Chaksu Gupta; Kirk J Wojno; Edward W Schervish
Late renal metastasis of endometrial adenocarcinoma.
The Journal of urology 2003;170(2 Pt 1):519.
2001: Y Q Wu; H Chen; Mark A Rubin; Kirk J Wojno; Kathleen Cooney
Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
Cancer research 2001;61(24):8651-3.
2001: Aaron P Moskalik; Mark A Rubin; Kirk J Wojno; Robert L Bree; Jonathan M Rubin; J Brian Fowlkes; James E Montie; S Manley; Paul Langford Carson
Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2001;20(7):713-22.
2001: Aaron P Moskalik; Paul Langford Carson; Jonathan M Rubin; Robert L Bree; J Brian Fowlkes; Mark A Rubin; Kirk J Wojno; S Manley; James E Montie
Analysis of three-dimensional ultrasound Doppler for the detection of prostate cancer.
Urology 2001;57(6):1128-32.
2001: James Varani; Yukari Hattori; Michael Dame; T Schmidt; Hedwig S Murphy; Kent J Johnson; Kirk J Wojno
Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue.
British journal of cancer 2001;84(8):1076-83.
2001: Kathleen Cooney; Myla S Strawderman; Kirk J Wojno; Kay M Doerr; A Taylor; KH Alcser; Steven G Heeringa; Jeremy Taylor; John T Wei; James E Montie; David Schottenfeld
Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men.
Urology 2001;57(1):91-6.
2000: Joseph G Washburn; Kirk J Wojno; Jyotirmoy Dey; Isaac J Powell; Jill A Macoska
8pter-p23 deletion is associated with racial differences in prostate cancer outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4647-52.
2000: Robert Marcovich; Kirk J Wojno; John T Wei; Mark A Rubin; James E Montie; Martin G Sanda
Bladder neck-sparing modification of radical prostatectomy adversely affects surgical margins in pathologic T3a prostate cancer.
Urology 2000;55(6):904-8.
2000: Jill A Macoska; T M Trybus; Kirk J Wojno
8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer.
Urology 2000;55(5):776-82.
2000: Ethan M Lange; H Chen; K Brierley; H Livermore; Kirk J Wojno; Carl D Langefeld; K Lange; Kathleen Cooney
The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(4):439-42.
2000: Mark A Rubin; MJ Putzi; NR Mucci; David C Smith; Kirk J Wojno; Susan Korenchuk; Kenneth J Pienta
Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):1038-45.
2000: Mark A Rubin; Nadir Bassily; Martin G Sanda; James E Montie; Myla S Strawderman; Kirk J Wojno
Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.
The American journal of surgical pathology 2000;24(2):183-9.
2000: Charlotte Becker; Timo Piironen; Kim Pettersson; Thomas Björk; Kirk J Wojno; JE Oesterling; Hans Lilja
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
The Journal of urology 2000;163(1):311-6.
1999: Imad Shureiqi; Kirk J Wojno; JA Poore; RG Reddy; MJ Moussalli; SA Spindler; Joel K Greenson; Daniel Normolle; Ahmed Hasan; Theodore S Lawrence; Dean E Brenner
Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.
Carcinogenesis 1999;20(10):1985-95.
1999: James Varani; Michael Dame; Kirk J Wojno; Lucia Schuger; Kent J Johnson
Characteristics of nonmalignant and malignant human prostate in organ culture.
Laboratory investigation; a journal of technical methods and pathology 1999;79(6):723-31.
1999: R Beduschi; MC Beduschi; Kirk J Wojno; M Jhung; Antoinette L Williams; J. Stuart Wolf, Jr.
Antifibrinolytic additives to fibrin glue for laparoscopic wound closure in urinary tract.
Journal of endourology / Endourological Society 1999;13(4):283-7.
1998: M A Prasad; T M Trybus; Kirk J Wojno; Jill A Macoska
Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.
Genes, chromosomes & cancer 1998;23(3):255-62.
1998: Kirk J Wojno; AR Vashi; P F Schellhammer; G L Wright; James E Montie
Percent free prostate-specific antigen values in men with recurrent prostate cancer after radical prostatectomy.
Urology 1998;52(3):474-8.
1998: WH Henricks; Barry G England; Donald Giacherio; JE Oesterling; Kirk J Wojno
Serum percent-free PSA does not predict extraprostatic spread of prostate cancer.
American journal of clinical pathology 1998;109(5):533-9.
1998: AR Vashi; Kirk J Wojno; B Gillespie; JE Oesterling
A model for the number of cores per prostate biopsy based on patient age and prostate gland volume.
The Journal of urology 1998;159(3):920-4.
1998: Meidee Goh; A H Tekchandani; Kirk J Wojno; Gary J Faerber
Metastatic Crohn's disease involving penile skin.
The Journal of urology 1998;159(2):506-7.
1997: James E Montie; Kirk J Wojno; E Klein; C Pearsall; H Levin
Transitional cell carcinoma in situ of the seminal vesicles: 8 cases with discussion of pathogenesis, and clinical and biological implications.
The Journal of urology 1997;158(5):1895-8.
1997: M J Häggman; Kirk J Wojno; C P Pearsall; Jill A Macoska
Allelic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma.
Urology 1997;50(4):643-7.
1997: M J Häggman; Jill A Macoska; Kirk J Wojno; JE Oesterling
The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues.
The Journal of urology 1997;158(1):12-22.
1997: Alan W Partin; Michael W Kattan; EN Subong; Patrick C Walsh; Kirk J Wojno; JE Oesterling; Peter T Scardino; Jay D Pearson
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
JAMA : the journal of the American Medical Association 1997;277(18):1445-51.
1997: Meidee Goh; Celina G Kleer; P Kielczewski; Kirk J Wojno; K Kim; JE Oesterling
Autologous blood donation prior to anatomical radical retropubic prostatectomy: is it necessary?
Urology 1997;49(4):569-73; discussion 574.
1997: AR Vashi; Kirk J Wojno; WH Henricks; B A England; Robert L Vessella; P H Lange; G L Wright; P F Schellhammer; R A Weigand; R M Olson; Barry Dowell; K K Borden; JE Oesterling
Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
Urology 1997;49(1):19-27.
1996: T D Richardson; Kirk J Wojno; L W Liang; Donald Giacherio; B G England; W H Henricks; A Schork; JE Oesterling
Half-life determination of serum free prostate-specific antigen following radical retropubic prostatectomy.
Urology 1996;48(6A Suppl):40-4.
1996: K Strohbehn; Leslie E Quint; Martin R Prince; Kirk J Wojno; John O L DeLancey
Magnetic resonance imaging anatomy of the female urethra: a direct histologic comparison.
Obstetrics and gynecology 1996;88(5):750-6.
1996: Kathleen Cooney; J C Wetzel; C M Consolino; Kirk J Wojno
Identification and characterization of proximal 6q deletions in prostate cancer.
Cancer research 1996;56(18):4150-3.
1996: Wael A Sakr; T M Wheeler; M Blute; M Bodo; R Calle-Rodrigue; D E Henson; F K Mostofi; J Seiffert; Kirk J Wojno; H Zincke
Staging and reporting of prostate cancer--sampling of the radical prostatectomy specimen.
Cancer 1996;78(2):366-8.
1996: TE Wilson; E A Doelle; Richard H Cohan; Kirk J Wojno; Melvyn Korobkin
Cystic renal masses: a reevaluation of the usefulness of the Bosniak classification system.
Academic radiology 1996;3(7):564-70.
1996: T M Trybus; A C Burgess; Kirk J Wojno; Thomas W Glover; Jill A Macoska
Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.
Cancer research 1996;56(10):2263-7.
1996: Kathleen Cooney; J C Wetzel; Sofia D Merajver; Jill A Macoska; Timothy P Singleton; Kirk J Wojno
Distinct regions of allelic loss on 13q in prostate cancer.
Cancer research 1996;56(5):1142-5.
1995: Jill A Macoska; T M Trybus; P D Benson; Wael A Sakr; David Grignon; Kirk J Wojno; T Pietruk; Isaac J Powell
Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.
Cancer research 1995;55(22):5390-5.
1989: Kirk J Wojno; W U Spitz
Necrotizing fasciitis: a fatal outcome following minor trauma. Case report and literature review.
The American journal of forensic medicine and pathology 1989;10(3):239-41.